Albemarle Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: -11.01%

Albemarle Corporation Return on Equity (ROE) is -11.01% for the Trailing 12 Months (TTM) ending March 31, 2025, a -431.61% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Albemarle Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 3.32%, a -91.10% change year over year.
  • Albemarle Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 37.30%, a 672.52% change year over year.
  • Albemarle Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 4.83%, a -39.81% change year over year.
  • Albemarle Corporation Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 8.02%, a -38.89% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share